Trim 25-30% of EMR at $147-148 zone; hard stop at $128; maintain 2% put hedge at $135
The binding constraints from prior reflection records reject passive Hold (alpha-cost-ceiling breached with -3.5% bleed across 8/21, 8/24, 8/26) and reject full Sell (structural quality anchors intact: 26.9% operating margins, 144% FCF conversion, $3.71B FCF covering dividend 3x, 69-year dividend streak, 200 SMA at $141.28 holding $6.35 above close). The 25-30% trim captures alpha-cost-ceiling benefit while honoring the 8/27 trim-tax warning against overshooting into a thin-catalyst window. The 50 SMA at $148.51 has already been broken — the trim trigger has already fired per the 8/31 lesson. Full capitulation is unwarranted given forward EPS trajectory toward $7.24 and redeployment optionality at $141-145 preserves participation if structural floor holds.
| Position | Action |
|---|---|
| Current position — execute this week | Trim 25-30% of EMR position at $147-148 zone |
| Residual position after trim | Hard stop at $128 (below Feb-Mar 2026 swing low) |
| Catastrophe insurance against goodwill impairment or peer-multiple compression | Maintain 2% notional put hedge at $135 strike, 60-90 day expiry |
| Confirmed technical reset — MACD histogram contraction and stabilization above lower Bollinger Band | Contingent buy-limit at $141-145 (200 SMA zone) for redeployment |
| Q3 print (~6-8 weeks) | Re-evaluate for re-engagement sizing |
The recent 9.9% pullback from $163.82 to $147.63 is a textbook shakeout offering a high-probability entry point, not a breakdown, supported by the Equinor 13-year contract win and best-in-class 26.9% operating margins at a reasonable 20.6x forward P/E.
| Indicator | Value | Signal |
|---|---|---|
| RSI(14) | 40.44 | neutral |
| MACD Line | 1.14 | bearish |
| MACD Signal | 2.83 | bearish |
| MACD Histogram | -1.69 | bearish |
| 10 EMA | 155.04 | bearish |
| 50 SMA | 148.51 | neutral |
| 200 SMA | 141.28 | bullish |
| VWMA (20) | 157.94 | bearish |
| ATR | 4.15 | neutral |
| Bollinger Upper Band | 166.34 | neutral |
| Bollinger Middle Band | 158.22 |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: MACD histogram contraction and stabilization above lower Bollinger Band at $141-145 zone
Then: Contingent buy-limit at $141-145 (200 SMA zone)
The Equinor 13-year frame agreement and BP automation contract represent transformative long-cycle revenue visibility that the market hasn't properly priced.
↩ rebuts: “Bear dismissed the Equinor/BP contracts as background noise.”
EV: +10% (T1: $163.82), +15% (T2: $170+), +22% (T3: $180+) · concedes: The data-center moratorium at 73% represents a potential headwind, though the bull notes this is based on a low-volume Polymarket market ($8,000) versus institutional-grade data; The 50 SMA at $148.51 was technically breached by 88 cents; The MACD did cross and price did break below the lower Bollinger band
EMR is a falling knife with premium valuation and no margin of safety — the technical breakdown is real, the valuation requires perfect execution, and the macro backdrop is unfavorable for multiple expansion.
EV: -$13 to -$17 (approximately -10% to -12% from current levels) · concedes: Q2 earnings beat ($1.28 EPS, +23% YoY) was a real print; Equinor/BP contracts represent 13-year preferred supplier relationships (maintenance revenue, not growth); 200 SMA at $141.28 is a reference level that may hold; Dividend provides some floor
→ vs conservative: Fundamentals (26.9% margins, 144% FCF, 69-year dividend streak) are intact but don't prevent 15-20% drawdowns when momentum rolls over; quality doesn't equal price is right
→ vs conservative: Waiting for dividend streak to save the position is hope, not strategy; $163.82 to $147.63 in 11 days proves this thesis can drop 10% fast
→ vs neutral: Waiting for 200 SMA confirmation at $141 means facing $130-135 downside; this is analysis paralysis that gives back gains
→ vs neutral: Hold-and-wait is same as long with no plan; eats downside without optionality of redeployment, worst of both worlds
| neutral |
| Bollinger Lower Band | 150.10 | bearish |
Support: 148.51 · 146.97 · 141.28 · 138.79 | Resistance: 155.04 · 157.94 · 158.22 · 163.82 · 166.34
EMR is in a short-term downtrend correction within a longer-term uptrend, having declined 9.9% from its August peak of $163.82 to close at $147.63. The MACD has crossed bearish with a histogram of -1.69, and price has breached the lower Bollinger band at $150.10, signaling stretched short-term conditions. The 50 SMA at $148.51 is the critical support to watch, while the 200 SMA at $141.28 marks major trend support. RSI at 40.44 indicates momentum is weakening but not yet oversold. The rating is HOLD for existing positions with stops tightened below $148.51.
Market Cap
$83.10B
P/E (TTM)
32.53
Forward P/E
20.56
PEG Ratio
1.7
Price/Book
4.08
Dividend Yield
1.5%
Forward EPS
$7.24
TTM EPS
$4.58
Revenue (TTM)
$18.64B
Net Income (TTM)
$2.58B
Gross Margin (TTM)
~53.2%
Operating Margin
26.9%
Net Profit Margin
13.8%
EBITDA (TTM)
$6.06B
ROE
12.8%
ROA
6.9%
Free Cash Flow (TTM)
$3.71B
FCF Conversion
~144%
Annual Dividends
~$1.2B
Total Assets
$41.94B
Total Equity
$20.28B
Total Debt
$13.92B
Net Debt
$11.57B
Current Ratio
0.896
Working Capital
-$1.68B
Goodwill + Intangibles
$27.1B
Tangible Book Value
-$7.1B
Debt-to-Equity
~67.7%
Q2 2026 Revenue
$4.56B
Q2 2026 Net Income
$618M
Q2 2026 Diluted EPS
$1.28
Q1 2026 Revenue
$4.35B
Q1 2026 Net Income
$605M
Q1 2026 Diluted EPS
$1.10
Q4 2025 Revenue
$4.86B
Q4 2025 Net Income
$636M
Q4 2025 Diluted EPS
$1.07
Q3 2025 Revenue
$4.55B
Q3 2025 Net Income
$586M
Q3 2025 Diluted EPS
$1.12
Q2 2025 Revenue
$4.43B
Q2 2025 Net Income
$485M
Q2 2025 Diluted EPS
$1.04
Q2 2025 Effective Tax Rate
31.6%
Restructuring Charges (Q2 2025)
$165M
Restructuring Charges (Q1 2026)
$46M
52-Week High
$166.35
52-Week Low
$122.64
50-Day MA
$148.99
200-Day MA
$142.37
Beta
1.235
Diluted Shares Outstanding
558.8M
Implied Stock Price
~$149
AspenTech Goodwill
$6.5B+
NI Goodwill
$6.6B
Strengths
Concerns
Emerson Electric has completed a major portfolio transformation, selling its Climate Technologies business and acquiring AspenTech and NI to become a pure-play automation/industrial software company. The company generates best-in-class profitability with 27% operating margins and converts 144% of net income to free cash flow ($3.71B TTM), driven by a high-margin software revenue mix. However, the valuation presents a bifurcated story: the TTM P/E of 32.5x appears expensive, but this compresses to a forward P/E of 20.6x if analysts' projected 58% EPS growth materializes — this gap between TTM and forward multiples is the central investment thesis and the primary risk if execution fails. The balance sheet carries $27.1B in goodwill/intangibles that must deliver synergies to avoid impairment, while the current ratio below 1.0 requires vigilant liquidity management during the deleveraging phase.
Macro: Soft-landing consensus with 8% US recession odds supports industrial order books. Fed on hold (89% no cuts in 2026) removes multiple expansion catalyst but remains neutral for cyclical capex demand. Oil price upside bias (WTI >$95 at 64%, >$100 at 34%) supports EMR's energy-major customer capex. Data-center moratorium risk (73%) represents real tail risk to AI/data-center narrative. Risk-on market tone overall with supportive broader market signals.